Physician profile
Timothy Davis
NPI 1770515603
$165,915.88
in general payments reported to CMS, 2019-2025
50 companies · $6,168 in 2025
The $6,168 reported for 2025 was more than what 96% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69K · 2020: $48K · 2021: $16K · 2022: $4,093 · 2023: $4,003 · 2024: $18K · 2025: $6,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Consulting Fee: $8,250 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,504 · Travel and Lodging: $2,026 · Education: $33.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,660.39 |
| Consulting Fee | $8,250.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,503.90 |
| Travel and Lodging | $2,025.98 |
| Education | $33.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $54,811.56 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Superion Indirect Decompression System |
| Vertiflex, INC. | $50,932.12 | 2019 | |
| Abbott Laboratories | $19,927.76 | 2019-2025 | Proclaim, Eterna |
| Biotronik Nro, INC. | $17,824.16 | 2023-2025 | Prospera, Biotronik |
| Surgalign Spine Technologies, INC. | $8,515.25 | 2019-2020 | |
| Medtronic, INC. | $5,981.34 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $2,423.42 | 2019-2024 | Senza |
| Si-Bone, INC. | $1,777.82 | 2023-2025 | |
| Ibsa Pharma INC. | $448.35 | 2020-2025 | Tirosint, Licart, Licart |
| Painteq LLC | $423.13 | 2021-2022 | |
| Nalu Medical, INC. | $355.71 | 2021-2025 | Nalu Neurostimulation System |
| Globus Medical, INC. | $342.02 | 2025 | Senza, Vyrsa V1 |
| Mesoblast, INC. | $177.57 | 2025 | Ryoncil |
| Arbor Pharmaceuticals, INC. | $175.12 | 2019-2021 | |
| Kerecis Limited | $149.86 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $121.90 | 2019-2021 | |
| Spinal Simplicity, LLC | $121.37 | 2022-2025 | Ha Minuteman G3-R |
| Vertex Pharmaceuticals Incorporated | $112.64 | 2025 | |
| Curonix LLC | $100.66 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Bioventus LLC | $100.01 | 2019-2025 | Xcell |
| 7d Surgical INC. | $91.53 | 2019 | |
| Relievant Medsystems, INC. | $71.98 | 2021 | |
| Biodelivery Sciences International, INC. | $67.45 | 2019-2021 | |
| Saluda Medical Americas, INC. | $64.81 | 2022 | |
| Azurity Pharmaceuticals, INC. | $63.89 | 2023-2024 | Horizant, Horizant |
| Virtus Pharmaceuticals LLC | $61.29 | 2022-2024 | Levorphanol Tartrate |
| Valinor Pharma, LLC | $59.63 | 2023-2024 | Movantik |
| Merz Pharmaceuticals, LLC | $57.20 | 2021-2024 | Xeomin |
| Radius Health, INC. | $54.75 | 2019 | |
| Medtronic USA, INC. | $53.50 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $50.47 | 2019-2020 | |
| Flowonix Medical Incorporated | $46.84 | 2019 | |
| Amgen INC. | $44.19 | 2019-2020 | |
| Stryker Corporation | $44.13 | 2020-2021 | |
| Redhill Biopharma INC. | $41.31 | 2020-2021 | |
| Neuronetics, INC. | $32.56 | 2023 | Neurostar Tms Therapy System |
| Daiichi Sankyo INC. | $23.13 | 2019 | |
| Djo, LLC | $22.95 | 2025 | Aircast |
| Depuy Synthes Sales INC. | $20.01 | 2023 | Orthovisc |
| Lilly USA, LLC | $19.64 | 2019 | |
| Ferring Pharmaceuticals INC. | $19.02 | 2025 | Euflexxa |
| Hydrocision, INC. | $17.78 | 2025 | Tenjet |
| Kowa Pharmaceuticals America, INC. | $17.36 | 2023 | Seglentis |
| Stratus Medical, LLC | $15.37 | 2020 | |
| Sentynl Therapeutics, INC. | $12.38 | 2020 | |
| Scilex Pharmaceuticals INC. | $11.55 | 2019 | |
| Spr Therapeutics, INC | $9.39 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$750,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.